Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLA-SE with Radiation in Metastatic Sarcoma
NCT02180698Phase 1Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Nov 2014
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of G100 in soft tissue sarcoma (STS), sponsored by Fred Hutchinson Cancer Center. Primary endpoint: Incidence of severe adverse events. Started Nov 2014; status: completed.
02
Drugs
G100
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT02180698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02180698.